Northern Trust’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Northern Trust’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-103,404	Closed	-$4.47M	–	4355
2015 Q3	$4.47M	Buy	103,404 +39,596	+62%	+$1.67M	﹤0.01%	2501
2015 Q2	$2.7M	Sell	63,808 -18,849	-23%	-$795K	﹤0.01%	2905
2015 Q1	$3.21M	Buy	82,657 +35,291	+75%	+$1.36M	﹤0.01%	2807
2014 Q4	$1.59M	Sell	47,366 -9,595	-17%	-$339K	﹤0.01%	3228
2014 Q3	$2M	Buy	56,961 +24,608	+76%	+$843K	﹤0.01%	3108
2014 Q2	$1.06M	Sell	32,353 -5,069	-14%	-$173K	﹤0.01%	3374
2014 Q1	$1.38M	Buy	+37,422	New	+$1.37M	﹤0.01%	3301

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Northern Trust's WX Position: Q4 2015 in Review

Northern Trust sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 103,404 shares — an estimated $4.47M sold.

Northern Trust first reported a position in WX in Q1 2014 and held it in 7 quarters. The position peaked at $4.47M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Northern Trust reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Northern Trust sold 103,404 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $4.47M.
Northern Trust first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 7 quarters.
Northern Trust's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $4.47M in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Northern Trust's 13F filing for Q4 2015, filed 12 Feb 2016.